Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| macrophage | 20 studies | 30% ± 11% | |
| classical monocyte | 19 studies | 29% ± 10% | |
| monocyte | 10 studies | 31% ± 18% | |
| non-classical monocyte | 10 studies | 23% ± 7% | |
| microglial cell | 7 studies | 45% ± 26% | |
| conventional dendritic cell | 6 studies | 22% ± 6% | |
| myeloid cell | 6 studies | 28% ± 8% | |
| alveolar macrophage | 4 studies | 24% ± 3% | |
| dendritic cell | 3 studies | 19% ± 1% | |
| mononuclear phagocyte | 3 studies | 20% ± 4% |
Insufficient scRNA-seq data for expression of FCGR1A at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| lung | 98% | 370.49 | 568 / 578 | 78% | 5.33 | 898 / 1155 |
| brain | 71% | 234.59 | 1867 / 2642 | 95% | 17.40 | 668 / 705 |
| kidney | 56% | 69.33 | 50 / 89 | 73% | 5.74 | 656 / 901 |
| breast | 41% | 45.64 | 186 / 459 | 87% | 5.59 | 978 / 1118 |
| adrenal gland | 86% | 159.12 | 223 / 258 | 30% | 1.39 | 68 / 230 |
| ovary | 28% | 24.99 | 51 / 180 | 78% | 5.15 | 334 / 430 |
| pancreas | 28% | 28.41 | 93 / 328 | 70% | 3.75 | 124 / 178 |
| spleen | 97% | 463.73 | 233 / 241 | 0% | 0 | 0 / 0 |
| bladder | 48% | 64.05 | 10 / 21 | 43% | 2.78 | 215 / 504 |
| uterus | 27% | 25.34 | 46 / 170 | 57% | 3.28 | 261 / 459 |
| thymus | 43% | 45.31 | 284 / 653 | 40% | 1.64 | 241 / 605 |
| lymph node | 0% | 0 | 0 / 0 | 83% | 18.43 | 24 / 29 |
| peripheral blood | 81% | 2649.90 | 756 / 929 | 0% | 0 | 0 / 0 |
| blood vessel | 79% | 219.42 | 1055 / 1335 | 0% | 0 | 0 / 0 |
| stomach | 22% | 24.77 | 78 / 359 | 49% | 2.79 | 141 / 286 |
| skin | 4% | 3.48 | 74 / 1809 | 66% | 5.87 | 313 / 472 |
| intestine | 36% | 39.78 | 346 / 966 | 34% | 1.75 | 181 / 527 |
| prostate | 57% | 60.62 | 140 / 245 | 11% | 0.32 | 56 / 502 |
| adipose | 66% | 124.30 | 794 / 1204 | 0% | 0 | 0 / 0 |
| esophagus | 20% | 19.87 | 289 / 1445 | 45% | 1.83 | 82 / 183 |
| tonsil | 0% | 0 | 0 / 0 | 62% | 3.32 | 28 / 45 |
| liver | 27% | 29.91 | 62 / 226 | 21% | 1.18 | 85 / 406 |
| heart | 33% | 36.82 | 280 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 19% | 0.96 | 15 / 80 |
| muscle | 1% | 0.89 | 10 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0050766 | Biological process | positive regulation of phagocytosis |
| GO_0006898 | Biological process | receptor-mediated endocytosis |
| GO_0045087 | Biological process | innate immune response |
| GO_0007165 | Biological process | signal transduction |
| GO_0001805 | Biological process | positive regulation of type III hypersensitivity |
| GO_0006911 | Biological process | phagocytosis, engulfment |
| GO_0006955 | Biological process | immune response |
| GO_0006910 | Biological process | phagocytosis, recognition |
| GO_0001788 | Biological process | antibody-dependent cellular cytotoxicity |
| GO_0042742 | Biological process | defense response to bacterium |
| GO_0042590 | Biological process | antigen processing and presentation of exogenous peptide antigen via MHC class I |
| GO_0038094 | Biological process | Fc-gamma receptor signaling pathway |
| GO_0001798 | Biological process | positive regulation of type IIa hypersensitivity |
| GO_0007166 | Biological process | cell surface receptor signaling pathway |
| GO_0009897 | Cellular component | external side of plasma membrane |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0031901 | Cellular component | early endosome membrane |
| GO_0030669 | Cellular component | clathrin-coated endocytic vesicle membrane |
| GO_0019770 | Molecular function | IgG receptor activity |
| GO_0019864 | Molecular function | IgG binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0019771 | Molecular function | high-affinity IgG receptor activity |
| Gene name | FCGR1A |
| Protein name | High affinity immunoglobulin gamma Fc receptor I (IgG Fc receptor I) (Fc-gamma RI) (FcRI) (Fc-gamma RIA) (FcgammaRIa) (CD antigen CD64) Fc gamma receptor Ia |
| Synonyms | FCGR1 IGFR1 FCG1 |
| Description | FUNCTION: High affinity receptor for the Fc region of immunoglobulins gamma. Functions in both innate and adaptive immune responses. Mediates IgG effector functions on monocytes triggering antibody-dependent cellular cytotoxicity (ADCC) of virus-infected cells. . |
| Accessions | C9JSN8 ENST00000444948.5 ENST00000369168.5 [P12314-1] P12314 |